OPS
ADMA icon

Orion Portfolio Solutions’s ADMA Biologics ADMA Stock Holding History

Orion Portfolio Solutions’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$751K Buy
+37,828
New +$654K 0.01% 1218
2023
Q4 		– Sell
-11,152
Closed -$39.9K – 1650
2023
Q3 		$39.9K Sell
11,152
-2,118
-16% -$8.15K ﹤0.01% 1599
2023
Q2 		$49K Hold
13,270
– – ﹤0.01% 1614
2023
Q1 		$43.9K Buy
+13,270
New +$45.9K ﹤0.01% 1546

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return

Orion Portfolio Solutions's ADMA Position: Q1 2025 in Review

Orion Portfolio Solutions opened a new position in ADMA Biologics (ADMA) in Q1 2025: 37,828 shares worth $751K. The stake represents 0.01% of the portfolio and ranks #1218 among its holdings. This is a return to the name: Orion Portfolio Solutions previously reported a position in ADMA as recently as Q3 2023.

Orion Portfolio Solutions first reported a position in ADMA in Q1 2023 and has held it in 4 quarters since. 347 funds tracked by Wall St. Rank hold ADMA as of Q1 2025.

  • Orion Portfolio Solutions held 37,828 shares of ADMA Biologics worth $751K as of Q1 2025.
  • ADMA Biologics was a new Orion Portfolio Solutions position in Q1 2025.
  • ADMA Biologics made up 0.01% of Orion Portfolio Solutions's portfolio in Q1 2025, its #1218 holding.
  • Orion Portfolio Solutions first reported a position in ADMA Biologics in Q1 2023 and has held it in 4 quarters since.
  • 347 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.